Enovix (NASDAQ:ENVX) Shares Gap Down on Analyst Downgrade

Key Points

• Enovix shares fell sharply after William Blair downgraded the stock from “outperform” to “market perform,” opening at $3.92 versus a prior close of $4.39 and later trading near $3.63.
• Analyst sentiment is mixed: six analysts rate Enovix a Buy, three a Hold and two a Sell. The consensus rating is “Hold,” with an average price target of $11.86.
• Enovix exceeded quarterly expectations, reporting an adjusted loss of $0.13 per share and revenue of $9.02 million, up 20.8% year over year, though the company continues to post substantial negative margins and return on equity.

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s stock price gapped down before the market opened on Monday after William Blair downgraded the stock from an outperform rating to a market perform rating. The stock had previously closed at $4.39, but opened at $3.92. Enovix shares last traded at $3.6250, with a volume of 4,544,490 shares changing hands.

Several other equities analysts also recently commented on ENVX. Weiss Ratings restated a "sell (e+)" rating on shares of Enovix in a research report on Wednesday, July 8th. Cantor Fitzgerald reissued an "overweight" rating and set a $25.00 target price on shares of Enovix in a research note on Thursday. Wall Street Zen raised Enovix from a "strong sell" rating to a "sell" rating in a report on Saturday, May 16th. Benchmark dropped their price target on Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, May 14th. Finally, Craig Hallum set a $7.00 price target on Enovix in a research note on Thursday. Six analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $11.86.

Institutional Trading of Enovix

A number of large investors have recently added to or reduced their stakes in the company. Private Advisor Group LLC grew its position in shares of Enovix by 2.7% in the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company's stock worth $464,000 after buying an additional 1,242 shares during the last quarter. Parallel Advisors LLC lifted its position in Enovix by 51.9% during the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company's stock valued at $39,000 after acquiring an additional 1,342 shares during the last quarter. Equitable Holdings Inc. lifted its position in Enovix by 10.9% during the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company's stock valued at $137,000 after acquiring an additional 1,342 shares during the last quarter. NewEdge Advisors LLC boosted its stake in Enovix by 4.7% in the first quarter. NewEdge Advisors LLC now owns 41,460 shares of the company's stock valued at $215,000 after acquiring an additional 1,853 shares in the last quarter. Finally, Mariner LLC boosted its stake in Enovix by 3.4% in the third quarter. Mariner LLC now owns 58,343 shares of the company's stock valued at $582,000 after acquiring an additional 1,921 shares in the last quarter. Institutional investors own 50.92% of the company's stock.

Enovix Stock Down 17.9%

The company's fifty day simple moving average is $5.33 and its 200-day simple moving average is $5.86. The company has a debt-to-equity ratio of 2.46, a current ratio of 9.71 and a quick ratio of 9.37. The firm has a market capitalization of $785.78 million, a PE ratio of -4.45 and a beta of 2.32.

Enovix (NASDAQ:ENVX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.The business had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same period in the prior year, the firm posted ($0.13) earnings per share. The business's quarterly revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. On average, analysts forecast that Enovix Corporation will post -0.78 EPS for the current year.

Enovix Company Profile

Enovix Corporation NASDAQ: ENVX develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source